Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Nephrology
Volume 2019, Article ID 2591560, 6 pages
https://doi.org/10.1155/2019/2591560
Case Report

Acute Kidney Failure in a Young African American Male

1Olive View-UCLA Medical Center, Division of Nephrology and Hypertension, Los Angeles, CA 91342, USA
2David Geffen School of Medicine at UCLA, Kidney Transplant, Los Angeles, CA 90095, USA

Correspondence should be addressed to Phuong Chi T. Pham; ude.alcu@ptcp

Received 11 December 2018; Accepted 3 February 2019; Published 17 February 2019

Academic Editor: Kouichi Hirayama

Copyright © 2019 Thuan V. Nguyen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Vaglio and F. Maritati, “Idiopathic retroperitoneal fibrosis,” Journal of the American Society of Nephrology, vol. 27, no. 7, pp. 1880–1889, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Engelsgjerd and C. A. LaGrange, “Retroperitoneal fibrosis,” in StatPearls [Internet], StatPearls Publishing, Treasure Island, Florida, 2018. View at Google Scholar
  3. E. F. H. Van Bommel, I. Jansen, T. R. Hendriksz, and A. L. H. J. Aarnoudse, “Idiopathic retroperitoneal fibrosis: Prospective evaluation of incidence and clinicoradiologic presentation,” Medicine, vol. 88, no. 4, pp. 193–201, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Raissian, S. H. Nasr, and C. P. Larsen, “Diagnosis of IgG4-related tubulointerstitial nephritis,” Journal of the American Society of Nephrology, vol. 22, no. 7, pp. 1343–1352, 2011. View at Publisher · View at Google Scholar
  5. N. C. Droz and S. D. Mathew, “A case of idiopathic retroperitoneal fibrosis associated with Sjögren’s Syndrome,” Military Medicine, vol. 181, no. 10, pp. e1407–e1409, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. T. A. Kermani, C. S. Crowson, S. J. Achenbach, and H. S. Luthra, “Idiopathic retroperitoneal fibrosis: A retrospective review of clinical presentation, treatment, and outcomes,” Mayo Clinic Proceedings, vol. 86, no. 4, pp. 297–303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. J. Scheel and N. Feeley, “Retroperitoneal fibrosis: The clinical, laboratory, and radiographic presentation,” Medicine, vol. 88, no. 4, pp. 202–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Liu, G. Zhang, Y. Niu, N. Jiang, and W. Xiao, “Retroperitoneal fibrosis: a clinical and outcome analysis of 58 cases and review of literature,” Rheumatology International, vol. 34, no. 12, pp. 1665–1670, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. S. Brandt, L. Kamper, S. Kukuk, P. Haage, and S. Roth, “Associated findings and complications of retroperitoneal fibrosis in 204 patients: Results of a urological registry,” The Journal of Urology, vol. 185, no. 2, pp. 526–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Lian, C. Wang, and J.-L. Tian, “IgG4-related retroperitoneal fibrosis: a newly characterized disease,” International Journal of Rheumatic Diseases, vol. 19, no. 11, pp. 1049–1055, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Khosroshahi, M. N. Carruthers, J. H. Stone et al., “Rethinking ormond's disease: “idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease,” Medicine, vol. 92, no. 2, pp. 82–91, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Zen, M. Onodera, D. Inoue et al., “Retroperitoneal fibrosis: A clinicopathologic study with respect to immunoglobulin G4,” The American Journal of Surgical Pathology, vol. 33, no. 12, pp. 1833–1839, 2009. View at Publisher · View at Google Scholar
  13. A. B. Crummy, W. B. Whittaker, J. F. Morrissey, and F. P. Cossman, “Intestinal infarction secondary to retroperitoneal fibrosis,” The New England Journal of Medicine, vol. 285, no. 1, pp. 28-29, 1971. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Jansen, T. R. Hendriksz, S. H. Han, A. W. L. C. Huiskes, and E. F. H. van Bommel, “18F-fluorodeoxyglucose position emission tomography (FDG-PET) for monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis,” European Journal of Internal Medicine, vol. 21, no. 3, pp. 216–221, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. E. F. H. van Bommel, C. Siemes, L. E. Hak, S. J. van der Veer, and T. R. Hendriksz, “Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone,” American Journal of Kidney Diseases, vol. 49, no. 5, pp. 615–625, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Vaglio, A. Palmisano, F. Alberici et al., “Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: An open-label randomised controlled trial,” The Lancet, vol. 378, no. 9788, pp. 338–346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. E. F. H. Van Bommel, T. R. Hendriksz, A. W. L. C. Huiskes, and A. G. M. Zeegers, “Brief communication: Tamoxifen therapy for nonmalignant retroperitoneal fibrosis,” Annals of Internal Medicine, vol. 144, no. 2, pp. 101–106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Jois, A. Gupta, and S. Krishnamurthy, “Ureteric vasculitis, an unusual presentation of polyarteritis nodosa: A case report,” International Journal of Rheumatic Diseases, vol. 18, no. 5, pp. 577–579, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. P. J. Scheel Jr., N. Feeley, and S. M. Sozio, “Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis: A case series,” Annals of Internal Medicine, vol. 154, no. 1, pp. 31–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Binder, M. Uhl, T. Wiech et al., “Cyclophosphamide is a highly effective and safe induction therapy in chronic periaortitis: A long-term follow-up of 35 patients with chronic periaortitis,” Annals of the Rheumatic Diseases, vol. 71, no. 2, pp. 311-312, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Marcolongo, I. M. Tavolini, F. Laveder et al., “Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: A retrospective analysis of 26 cases,” American Journal of Medicine, vol. 116, no. 3, pp. 194–197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Alberici, A. Palmisano, M. L. Urban et al., “Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis,” Annals of the Rheumatic Diseases, vol. 72, no. 9, pp. 1584–1586, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Maritati, D. Corradi, A. Versari et al., “Rituximab therapy for chronic periaortitis,” Annals of the Rheumatic Diseases, vol. 71, no. 7, pp. 1262–1264, 2012. View at Publisher · View at Google Scholar · View at Scopus